Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
08/2009
08/13/2009WO2009074575A3 Organic compounds
08/13/2009WO2008080268A8 Derivates of substituted tartaric aicd and usage for preparating beta secretase inhibitors
08/13/2009US20090203910 Deprotection of N-BOC compounds
08/13/2009US20090203909 Method and apparatus for the use of [11C] Carbon Monoxide in Labeling Synthesis by Photo-Initiated Carbonylation
08/13/2009US20090203904 Arylsulfinate salts in photoinitiator systems for polymerization reactions
08/13/2009US20090203706 Lysine-based polymeric linkers
08/13/2009US20090203702 INHIBITORS OF p38
08/13/2009US20090203696 Aryl- and Heteroaryl-Ethyl-Acylguanidine Derivatives, Their Preparation and Their Application in Therapeutics
08/13/2009CA2714226A1 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
08/12/2009EP2088143A1 Novel inhibitors of mycobacterium tuberculosis complex cytochrome P450 CYP121
08/12/2009EP1429771B1 Bicyclic compounds as inhibitors of chemokine binding to us28
08/12/2009EP0788360B3 Boronic ester and acid compounds, synthesis and uses
08/12/2009CN101506196A Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses
08/12/2009CN100526301C 1,2-di(cyclic) substituted benzene compounds
08/11/2009US7572911 Azotization of 5-amino-3-t-butyl-4-cyanopyrazole, then reacting with couplers and alkylation or arylation, to form azo dyes, used as inks having colorfastness; liquid crystal displays and plasma display panels; excellent color reproducibility
08/11/2009US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid
08/11/2009US7572787 Substituted naphthalene sulfonamides
08/06/2009WO2009096555A1 Method for producing compound having deuterated aromatic ring or heterocyclic ring
08/06/2009WO2009096198A1 Novel biaryl derivative
08/06/2009WO2009095872A2 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
08/06/2009WO2009095399A2 Pyrazine derivatives and their use as protein kinase inhbitors
08/06/2009US20090198053 Pyrazine Derivatives and Uses Thereof in Renal Monitoring
08/06/2009US20090197891 Use of (4-Alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer's disease
08/06/2009US20090197888 Fluorinated tripeptide hcv serine protease inhibitors
08/06/2009US20090197065 Birefringent film, production method thereof and use thereof
08/06/2009CA2713553A1 Pyrazine derivatives and their use as protein kinase inhibitors
08/05/2009EP2085390A1 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
08/05/2009EP2084138A1 Quinoxaline derivative, and light-emitting element and light-emitting device using quinoxaline derivative
08/05/2009EP1805144A4 Heterocyclical chromophore architectures
08/05/2009EP1473289B1 Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
08/05/2009EP1249233B9 Npyy5 antagonists
08/05/2009EP1186594B1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
08/05/2009CN101501008A Arylpiperazine derivatives and uses thereof
08/05/2009CN101500997A PARP inhibitors
08/05/2009CN100522965C 8-arylamine-3H-imidazole [4,5-g] quinazoline derivatives and its solid phase synthesis method
08/05/2009CN100522949C Piperazinedione compounds
08/05/2009CN100522171C 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
08/04/2009US7569691 Protected piperazino group-bearing organoxysilane compound and making method
08/04/2009US7569690 Process for producing oxycarbonyl-substituted piperazine derivative
08/04/2009US7569689 Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
08/04/2009CA2568104C Intermediates useful in production of antivirally active heterocyclic azahexane derivatives
07/2009
07/30/2009US20090192172 2-Alkyl-Cycloalk(en)yl-Carboxamides
07/30/2009US20090192136 Benzoyl-piperazine derivatives
07/30/2009US20090192122 Inflammatory cytokine release inhibitor
07/30/2009US20090191394 Oarganic Compound, Optical Crystal Film and Method of Production Thereof
07/30/2009US20090191227 Compositions and Methods for Enhancing Immune Responses to Vaccines
07/30/2009US20090191125 Diagnostic and Therapeutic Alkyl Piperidine/Piperazine Compounds and Process
07/29/2009EP2081912A1 Heterocyclic bridged biphenyls and their use in oleds
07/29/2009EP2081888A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
07/29/2009EP1409468B9 Guanidinobenzamides as mc4-r agonists
07/29/2009EP1268443B1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
07/29/2009CN101492416A Compounds effecting glucokinase
07/29/2009CN100519527C Inhibitors of histone deacetylase
07/28/2009US7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system
07/23/2009WO2009091884A1 High dielectric constant liquid crystal
07/23/2009WO2009091014A1 Phenyl acetamide derivative
07/23/2009WO2009042114A3 Phenazine derivatives and uses thereof
07/23/2009WO2009005671A3 Substituted piperazines as cb1 antagonists
07/23/2009US20090186900 Compound
07/23/2009US20090186867 Substituted Diketopiperazines As Oxytocin Antagonists
07/23/2009CA2712948A1 Phenylacetamide derivative
07/22/2009EP1750704B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
07/22/2009CN101490017A Therapeutic piperazines as PDE4 inhibitors
07/22/2009CN101486686A Two compounds with quinoxaline mother ring and preparation thereof
07/21/2009US7563895 Quinoxaline compounds
07/21/2009US7563795 Phenyl-piperazine derivatives as modulators of muscarinic receptors
07/21/2009US7563793 Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents
07/16/2009WO2009089234A2 Substituted dibenzhydrylpiperazines
07/16/2009US20090181972 Novel Inhibitors of Cysteine Proteases, the Pharmaceutical Compositions Thereof and their Therapeutic Applications
07/16/2009US20090181967 New compounds I
07/16/2009US20090181951 Parp inhibitors
07/16/2009US20090181943 Inhibitors of Histone Deacetylase
07/16/2009US20090181940 Imidazopyrazine Tyrosine Kinase Inhibitors
07/15/2009EP2078720A1 Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained and uses thereof
07/15/2009EP2078000A1 Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators
07/15/2009EP1863774A4 Heterocyclical chromophore architectures with novel electronic acceptor systems
07/15/2009EP1805150A4 Heterocyclical chromophore architectures
07/15/2009CN101484430A Theanine derivatives, uses thereof and processes for the manufacture thereof
07/15/2009CN101481357A Preparation of quinoxaline derivatives
07/15/2009CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes
07/14/2009US7560483 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable
07/14/2009US7560463 Diaryl ethers as opioid receptor antagonists
07/14/2009US7560462 Compounds useful for inhibiting CHK1
07/14/2009US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR)
07/14/2009CA2335285C Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
07/09/2009WO2009083532A2 Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained, and uses thereof
07/09/2009US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
07/09/2009US20090176984 Isotopically Enriched N-Substituted Piperazine Acetic Acids And Methods For The Preparation Thereof
07/09/2009US20090176803 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists
07/09/2009US20090176792 Substituted dibenzhydrylpiperazines
07/09/2009US20090176775 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use
07/09/2009US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction
07/08/2009EP2076500A1 Phenazine and quinoxaline substituted amino acids and polypeptides
07/08/2009EP2076499A2 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators
07/08/2009EP2076494A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds
07/08/2009EP2076491A1 New benzamide derivatives as bradykinin antagonists
07/08/2009EP2076252A2 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
07/08/2009CN101479238A Amine derivative having npyy5 receptor antagonist activity
07/08/2009CN100509811C Azaindoles
07/08/2009CN100509790C Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 187